By ThinkSabio #ThinkSabio Latest News
Announces Data from Cohort 2 of Placebo-Controlled Phase 1 Trial of Soquelitinib for Atopic Dermatitis Conference on Wednesday, January 15 at 2:15 pm ET / 11:15 am PT
Subscribe
for ThinkSabio Updates !
We'll keep you up to date about our Stocks, Sec Alerts , Trendings Stocks etc..